|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Fortress Biotech, Inc. (FBIO) |
|
|
$0.29 0.00 (0.00%) as of 4:30 Mon 10/9
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
93,700,000 |
| Market
Cap: |
26.82(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2833 - $0.7214 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates. Through its partner company, Co. markets dermatology products including Qbrexza®, which is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane® (isotretinoin) capsule, which is an oral retinoid indicated for the treatment of severe recalcitrant nodular acne; as well as Ximino® (minocycline hydrochloride) extended release capsule, which is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
50,000 |
1,884,573 |
6,046,667 |
| Total Buy Value |
$0 |
$118,770 |
$3,272,775 |
$6,715,834 |
| Total People Bought |
0 |
1 |
2 |
6 |
| Total Buy Transactions |
0 |
1 |
6 |
16 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Avgerinos George |
SVP, Biologics Operations |
• – – |
2016-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
308,000 |
|
- |
|
| Klein Dov |
Director |
– • – |
2016-07-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,333) |
141,667 |
|
- |
|
| Rosenwald Lindsay A Md |
President and CEO |
• • • |
2016-06-01 |
4 |
B |
$2.40 |
$1,471 |
D/D |
613 |
5,303,739 |
3.15 |
- |
|
| Rowinsky Eric K |
Director |
– • – |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
250,000 |
|
- |
|
| Lobell J Jay |
Director |
– • – |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
586,000 |
|
- |
|
| Weiss Michael S |
Exec. VC - Strategic Dev. |
• • • |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
510,434 |
7,448,472 |
|
- |
|
| Rosenwald Lindsay A Md |
President and CEO |
• • • |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
510,434 |
5,303,126 |
|
- |
|
| Klein Dov |
Director |
– • – |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
155,000 |
|
- |
|
| Rosenwald Lindsay A Md |
President and CEO |
• • • |
2015-12-01 |
4 |
B |
$2.41 |
$1,412 |
D/D |
586 |
4,792,692 |
3.15 |
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-11 |
4 |
D |
$2.68 |
$83,900 |
D/D |
(31,299) |
158,000 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-10 |
4 |
D |
$2.62 |
$59,555 |
D/D |
(22,737) |
189,299 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-09 |
4 |
D |
$2.62 |
$36,941 |
D/D |
(14,100) |
212,036 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-08 |
4 |
D |
$2.57 |
$30,102 |
D/D |
(11,704) |
226,136 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-04 |
4 |
D |
$2.60 |
$5,554 |
D/D |
(2,136) |
237,840 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-03 |
4 |
D |
$2.58 |
$47,029 |
D/D |
(18,200) |
239,976 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-02 |
4 |
D |
$2.60 |
$64,690 |
D/D |
(24,900) |
258,176 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-09-01 |
4 |
D |
$2.70 |
$427 |
D/D |
(158) |
283,076 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-08-31 |
4 |
D |
$2.94 |
$10,295 |
D/D |
(3,500) |
283,234 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-08-21 |
4 |
D |
$2.55 |
$25,458 |
D/D |
(10,000) |
286,734 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-08-19 |
4 |
D |
$3.00 |
$33,798 |
D/D |
(11,266) |
296,734 |
|
- |
|
| Avgerinos George |
SVP, Biologics Operations |
• – – |
2015-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
308,000 |
|
- |
|
| Klein Dov |
Director |
– • – |
2015-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,800 |
|
- |
|
| Klein Dov |
Director |
– • – |
2015-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| Klein Dov |
Director |
– • – |
2015-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
55,000 |
|
- |
|
| Rosenwald Lindsay A Md |
President and CEO |
• • • |
2015-06-01 |
4 |
B |
$1.80 |
$1,413 |
D/D |
785 |
4,792,106 |
3.15 |
- |
|
156 Records found
|
|
Page 6 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
